UGT1A polymorphisms associated with worse outcome in colorectal cancer patients treated with irinotecan-based chemotherapy

被引：0
|
作者：
Qianqian Yu
Tao Zhang
Conghua Xie
Hong Qiu
Bo Liu
Liu Huang
Ping Peng
Jueping Feng
Jigui Chen
Aihua Zang
Xianglin Yuan
机构：
[1] Huazhong University of Science and Technology,Department of Oncology, Tongji Hospital, Tongji Medical College
[2] Huazhong University of Science and Technology,Cancer Center, Union Hospital, Tongji Medical College
[3] Wuhan University,Department of Radiation and Medical Oncology, Zhongnan Hospital
[4] Huazhong University of Science and Technology,Department of Oncology, PuAi Hospital, Tongji Medical College
[5] Wuhan 8th Hospital,Department of Surgery
[6] Hubei Cancer Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2018年 / 82卷
关键词：
Polymorphism; Irinotecan; Outcome; Metastatic colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：87 / 98
页数：11
相关论文
共 50 条
  • [41] Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
    Aparicio, T
    Desramé, J
    Lecomte, T
    Mitry, E
    Belloc, J
    Etienney, I
    Montembault, S
    Vayre, L
    Locher, C
    Ezenfis, J
    Artru, P
    Mabro, M
    Dominguez, S
    BRITISH JOURNAL OF CANCER, 2003, 89 (08) : 1439 - 1444
  • [42] Predictive effects of bilirubin on response of colorectal cancer to irinotecan-based chemotherapy
    Qian-Qian Yu
    Hong Qiu
    Ming-Sheng Zhang
    Guang-Yuan Hu
    Bo Liu
    Liu Huang
    Xin Liao
    Qian-Xia Li
    Zhi-Huan Li
    Xiang-Lin Yuan
    World Journal of Gastroenterology, 2016, (16) : 4250 - 4258
  • [43] Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
    T Aparicio
    J Desramé
    T Lecomte
    E Mitry
    J Belloc
    I Etienney
    S Montembault
    L Vayre
    C Locher
    J Ezenfis
    P Artru
    M Mabro
    S Dominguez
    British Journal of Cancer, 2003, 89 : 1439 - 1444
  • [44] Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
    C Alliot
    M Barrios
    British Journal of Cancer, 2004, 90 : 2050 - 2051
  • [45] Association between UGT1A1*28 Polymorphisms and Clinical Outcomes of Irinotecan-Based Chemotherapies in Colorectal Cancer: A Meta-Analysis in Caucasians
    Liu, Xiang
    Cheng, Dangxiao
    Kuang, Qin
    Liu, Geoffrey
    Xu, Wei
    PLOS ONE, 2013, 8 (03):
  • [46] Polymorphisms of the UDP-Glucuronosyl Transferase 1A Genes Are Associated with Adverse Events in Cancer Patients Receiving Irinotecan-Based Chemotherapy
    Inoue, Kazuyuki
    Sonobe, Momoyo
    Kawamura, Yukinori
    Etoh, Takashi
    Takagi, Masakazu
    Matsumura, Takashi
    Kikuyama, Masataka
    Kimura, Midori
    Minami, Sato
    Utsuki, Hiroaki
    Yamazaki, Tomoaki
    Suzuki, Takayo
    Tsuji, Daiki
    Hayashi, Hideki
    Itoh, Kunihiko
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 229 (02): : 107 - 114
  • [47] Pharmacogenetic analysis of TS and UGT1A polymorphisms predictive for response and toxicity in Spanish patients with advanced colorectal cancer treated with first-line irinotecan and 5-fluorouracil
    Martinez-Balibrea, E.
    Abad, A.
    Valladares, M.
    Martinez-Villacampa, M.
    Aranda, E.
    Marcuello, E.
    Benavides, M.
    Martinez-Cardus, A.
    Gines, A.
    Manzano, J. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] UGT1A1 gene polymorphism: Impact on toxicity and efficacy of irinotecan-based regimens in metastatic colorectal cancer
    Christoph Schulz
    Volker Heinemann
    Andreas Schalhorn
    Nikolas Moosmann
    Thomas Zwingers
    Stefan Boeck
    Clemens Giessen
    Hans-Joachim Stemmler
    World Journal of Gastroenterology, 2009, 15 (40) : 5058 - 5066
  • [49] UGT1A1 gene polymorphism: Impact on toxicity and efficacy of irinotecan-based regimens in metastatic colorectal cancer
    Schulz, Christoph
    Heinemann, Volker
    Schalhorn, Andreas
    Moosmann, Nikolas
    Zwingers, Thomas
    Boeck, Stefan
    Giessen, Clemens
    Stemmler, Hans-Joachim
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (40) : 5058 - 5066
  • [50] UGT1A1 PROMOTER GENOTYPE AND TOXICITY IN PATIENTS WITH ADVANCED COLORECTAL CANCER TREATED WITH IRINOTECAN-CONTAINING CHEMOTHERAPY
    Chiara, S.
    Gargiulo, L.
    Marroni, P.
    Serra, M.
    Tomasello, L.
    Pastrone, I.
    Paganuzzi, M.
    Notaro, R.
    ANNALS OF ONCOLOGY, 2004, 15 : 43 - 43
12345